-

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares.

"The investigation has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and proposed $9.50 per share price unfair to Amex GBT shareholders. "

Share

Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/

On May 4, 2026, Amex GBT announced that it had agreed to be privatized for $9.50 per share in cash. Upon completion of the proposed transaction, Amex GBT’s public shareholders will be cashed out of their investment position, and the company’s shares will no longer be publicly traded.

Our investigation has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and proposed $9.50 per share price unfair to Amex GBT shareholders. Notably, at the time the buyout was announced, at least one stock analyst was maintaining a price target for Amex GBT’s shares of $12.00 per share – over 25% higher than the buyout price.

Amex GBT shareholders who feel that the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email at abell@kaskelalaw.com, for additional information about their legal rights and options. Investors may also request additional information about this matter by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/global-business-travel-group/

ABOUT KASKELA LAW:

Kaskela Law exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent-fee basis. For additional information about the firm, including the firm’s recent monetary recoveries for investors in mergers & acquisition litigation, please visit our website (www.kaskelalaw.com) or contact us today at (888) 715 – 1740.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esquire
Adrienne Bell, Esquire
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NYSE:GBTG
Release Versions
English

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esquire
Adrienne Bell, Esquire
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation Into Proposed Buyout of The Baldwin Insurance Group, Inc. (BWIN) Shareholders at $32.50 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the recently announced proposed buyout of The Baldwin Insurance Group, Inc. (NASDAQ: BWIN) (“Baldwin”) shareholders to determine whether the proposed buyout price undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/baldwin-group-buyout/ On September 14, 2026, Baldwin announced that it would be acquired by Sequence Holdings and DFO Manag...

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine whether the proposed buyout price undervalues the company’s shares.Click here for additional information: https://kaskelalaw.com/case/surgery-partners/On October 26, 2026, Surgery Partners announced that it had agreed to be acquired by HealthSpan Partners at a price of $23.50 per share in cash. Follo...

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Investigation into Proposed Buyout of CCC Intelligent Solutions Holdings (CCC) Shareholders at $7.75 Per Share – Fair Price or Insufficiently Low?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law announces that it has launched an investigation into the fairness of the recently announced proposed buyout of CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) (“CCC”) shareholders to determine whether the proposed buyout price undervalues the company’s shares.Click here for additional information: https://kaskelalaw.com/case/ccc-intelligent-solutions-holdings/On October 15, 2026, CCC announced that it had agreed to be acquired by a consortium of p...
Back to Newsroom